Cytolytic effector mechanisms of human CD4+ cytotoxic T lymphocytes

Human Immunology

Volumn 45, Issue 1, 1996, Pages 64-75

  Susskind, Brian ^a,c   Shornick, Michael D ^a   Iannotti, Michael R ^a   Duffy, B ^a   Tanden, P Mehrotra Nee ^b   Siegel, Jay P ^b   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CD4 ANTIGEN; CYTOCHALASIN B; GRANZYME B; HLA DR ANTIGEN; MONENSIN; RUTHENIUM RED; SERINE PROTEINASE INHIBITOR; TOSYLLYSYL CHLOROMETHYL KETONE; VERAPAMIL;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; CALCIUM TRANSPORT; CELL CLONING; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0029921544     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(95)00151-4     Document Type: Article

References (57)

1. Roberts RL, Ank BJ, Stiehm ER: Human eosinophils are more toxic than neutrophils in antibody-independent killing. J Allergy Clin Immunol 87:1105, 1991.
2. Lopez DM, Blomberg BB, Padmanabhan RR, Bourguignon LYW: Nuclear disintegration of target cells by killer B lymphocytes from tumor-bearing mice. FASEB J 3:37, 1989.
3. Decker T, Lohmann-Mathes M-L, Gilford GE: Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immunol 138: 957, 1987.
4. + T cell subsets: the role of granule exocytosis. J Immunol 151:740, 1993.
5. Strack P, Martin C, Saito S, Dekruyff RH, Ju S-T: Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones. Eur J Immunol 20:179, 1990.
6. + T cell-mediated cytotoxicity. J Immunol 152:1127, 1994.
7. Smyth MJ, Norihisa Y, Ortaldo JR: Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets. J Immunol 148:55, 1992.
8. Lobe CG, Havele C, Bleackley RC: Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes. Proc Natl Acad Sci USA 83:1448, 1986.
9. Henkart PA: Mechanisms of lymphocyte mediated cytotoxicity. Annu Rev Immunol 3:31, 1985.
10. Podack ER, Lowrey DM, Lichtenheld M, Olsen KJ, Aebischer T, Binder D, Rupp F, Hengartner H: Structure, function, and expression of murine and human perforin 1 (P1). Immunol Rev 103:203, 1988.
11. Tschopp J, Nabholz M: Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 8:279, 1990.
12. Zychlinsky A, Joag S, Liu C-C, Young JD-E: Cytotoxic mechanisms of murine lymphokine-activated killer cells: functional and biochemical characterization of homogeneous populations of spleen LAK cells. Cell Immunol 126:377, 1990.
13. Young JD-E, Lu C-C, Persechini PM, Cohn ZA: Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Immunol Rev 103:161, 1988.
14. Berke G: Lymphocyte-mediated cytolysis: effectors, lytic signals, and the mechanism whereby early membrane derangements result in target-cell death. Ann NY Acad Sci 532:314, 1988.
15. Munger WE, Berrebi GA, Henkard PA: Possible involvement of CTL granule proteases in target cell DNA breakdown. Immunol Rev 103:99, 1988.
16. Ju S-T, Ruddle NH, Strack P, Dorf ME, Dekruyff RH: Expression of two distinct cytolytic mechanisms among murine CD4 subsets. J Immunol 144:23, 1990.
17. Hadley GA, Mohanakumar T: Kidney cell-restricted recognition of MHC class I alloantigens by human cytolytic T-cell clones. Transplantation 55:400, 1993.
18. Mathew JM, Marsh JW, Susskind B, Mohanakumar T: Analysis of T cell responses in liver allograft recipients: evidence for deletion of donor specific cytotoxic T cells in the peripheral circulation. J Clin Invest 91:900, 1993.
19. Ellis TM, Mohanakumar T: Dissociation of autologous and allogeneic mixed lymphocyte reactivity by using a monoclonal antibody specific for human T helper cells. J Immunol 131:2323, 1983.
20. Carpen O, Virtanen I, Saksela E: The cytotoxic activity of human NK cells requires an intact secretory apparatus. Cell Immunol 58:97, 1981.
21. Pasternak MS, Sitkovsky MV, Eisen HN: The site of action of N-alpha-tosyl-L-lysyl-chloromethyl-ketone on cloned cytotoxic T lymphocytes. J Immunol 131:2477, 1983.
22. Berke G: Cytotoxic T lymphocytes. How do they function? Immunol Rev 72:5, 1983.
23. Ostergaard HL, Clark WR: Evidence for multiple lytic pathways used by cytotoxic T lymphocytes. J Immunol 143:2120, 1989.
24. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P: A polyadenylate binding protein localized to granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629, 1991.
25. Sheehan KC, Ruddle NH, Schreiber RD: Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factor. J Immunol 142: 3884, 1989.
26. Chomczynski P, Saachi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 164:950, 1986.
27. Weis JH, Ausubel FM, Brent R, Kingston RE, et al. (eds): Conversion of mRNA into double stranded cDNA. In: Current Protocols in Molecular Biology. Brooklyn, Wiley Interscientific, 1991, p 5.5.2.
28. Lipman ML, Stevens AC, Bleackley RC, Helderman JH, McCune TR, Harmon WE, Shapiro ME, Rosen S, Strom TB: The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 53:73, 1992.
29. Shi L, Kraut RP, Powers JC, Aebersold R, Greenberg AH: Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 176:1521, 1992.
30. Nakajima H, Henkart PA: Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. J Immunol: 1057, 1994.
31. Talento A, Nguyen M, Law S, Wu JK, Poe M, Blake JT, Patel M, Wu T-J, Manyak CL, Silberklang M, et al.: Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity. J Immunol 149:4009, 1992.
32. Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KL, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31, 1994.
33. Heusel JW, Wesselschmidt RL, Shresta S, Russel JH, Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977, 1994.
34. Zanovello P, Rosato A, Bronte V, Cerundolo V, Treves S, Di Virgilio F, Pozzan T, Biassi G, Collavo D: Interaction of lymphokine-activate killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis. J Exp Med 170:665, 1989.
35. Clark W, Ostergaard H, Gorman K, Torbet B: Molecular mechanisms of CTL-mediated lysis: a cellular perspective. Immunol Rev 103:37, 1988.
36. Sitkovsky MV: Mechanistic, functional and immunopharmacological implications of biochemical studies of antigen receptor-triggered cytolytic T-lymphocyte activation. Immunol Rev 103:127, 1988.
37. Walsh CM, Glass AA, Chiu V, Clark WR: The role of the fas lytic pathway in a perforin-less CTL hybridoma. J Immunol 153:2506, 1994.
38. Ratner A, Clark W: Role of TNF-α in acute CTL-mediated lysis. J Immunol 150:4303, 1993.
39. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195, 1993.
40. + cytolytic T cells kill antigen-pulsed target T cells by induction of apoptosis. J Immunol 150:4856, 1993.
41. Ishidate M, Metcalf D: The pattern of lymphopoiesis in the mouse after cortisol administration or adrenalectomy. Aust J Exp Biol Med Sci 41:637, 1963.
42. Mercep M, Bluestone JA, Noguchi PD, Ashwell JD: Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J Immunol 140:324, 1988.
43. + killer T cells. J Immunol 144:790, 1990.
44. H2 subsets: doubt no more. Immunol Today 12:257, 1991.
45. + lymphocytes. J Immunol 146:3242, 1991.
46. + T cell clones cycles in response to IL-2. J Immunol 151:4055, 1993.
47. Braakman E, Rotteveel FTM, van Bleek G, van Seventer GA, Lucas CJ: Are MHC class II-restricted cytotoxic T lymphocytes important? Immunol Today 8:265, 1987.
48. + T lymphocytes in culture. Nature 308:365, 1984.
49. McKisic MD, Lancki DW, Fitch FW: Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background. J Immunology 150:3793, 1993.
50. Wagner H, Starzinski-Powitz A, Jung A, Rollinghoff M: Induction of I region-restricted hapten-specific cytotoxic T lymphocytes. J Immunol 119:1365, 1977.
51. Tite JP, Powell MB, Ruddle NH: Protein-antigen specific Ia-restricted cytolytic T cell: analysis of frequency, target cell susceptibility, and mechanism of cytolysis. J Immunol 135:25, 1985.
52. Lukacher AE, Morrison LA, Braciale VL, Malissen B, Braciale TJ: Expression of specific cytolytic activity by H-2 I-regin-restricted, influenza virus-specific T lymphocyte clones. J Exp Med 162:171, 1985.
53. + human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 133:754, 1984.
54. Ottenhoff T, Mutis T: Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones: a novel potentially immunoregulatory T-T cell interaction in man. J Exp Med 171:2011, 1990.
55. Eljaafari A, Dorval I, Zeliszewski D: Requirements for lysis of activated T cells by class-II-restricted cytolytic T-Iymphocytes. Hum Immunol 35:50, 1992.
56. Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignami S: T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 334:530, 1988.
57. + cell depletion. Cell 54:561, 1989.